Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-27 @ 11:35 PM
Study NCT ID:
NCT04659434
Status:
UNKNOWN
Last Update Posted:
2020-12-09
First Post:
2020-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab Plus R-GemOx as Second-line Salvage Therapy in Patients With R/R DLBCL
Sponsor:
Qian Wenbin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-10
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-26
First Submit QC Date:
None
Study First Post Date:
2020-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-02
Last Update Post Date:
2020-12-09
Last Update Post Date Type:
ACTUAL